ATTR-ACT: Tafamidis Reduces Mortality in Amyloid Cardiomyopathy ATTR-ACT: Tafamidis Reduces Mortality in Amyloid Cardiomyopathy

A drug that binds transthyretin reduced all-cause mortality and cardiovascular hospitalizations and slowed decline in functional capacity in patients with transthyretin amyloid cardiomyopathy.Medscape Medical News
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Cardiology News Source Type: news